Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Lantheus Announces Presentation of Data at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
GlobeNewswire, Inc.
BEDFORD, Mass., May 19, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the Company) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient...
Stephen Shaya, M.D. Honored in Historic Exchange Between the Imperial House of Brazil and Swedish Orders
EIN Presswire
STOCKHOLM, SWEDEN, May 13, 2026 /EINPresswire.com/ -- Stephen Shaya, M.D., Executive Servant Leader of J&B Medical and Managing Director of Akkad Holdings, was honored during a historic exchange of honors between the Imperial House of Brazil,...
Berry Street Partners with Factor, Bringing Personalized Nutrition Therapy to Leading Meal Delivery Service
GlobeNewswire, Inc.
NEW YORK, May 13, 2026 (GLOBE NEWSWIRE) -- Berry Street, the leading metabolic health company transforming nutrition therapy, and Factor, America’s leading ready-to-heat meal delivery service, today announced a new partnership to provide...
Climb Bio to Present New Budoprutug Clinical Data at European Hematology Association (EHA) 2026 Congress
GlobeNewswire, Inc.
WELLESLEY HILLS, Mass., May 14, 2026 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical stage biotechnology company developing therapeutics for patients with immune-mediated diseases, today announced an upcoming presentation on its...
Nordic leaders gather in Stockholm to discuss the future of Responsible AI.
EIN Presswire
SamurAI by NTT Security and EARTH 51 bring together senior leaders to address AI governance, resilience and institutional readiness.
Ascentage Pharma to Present 17 Clinical Advances at 2026 European Hematology Association Congress
GlobeNewswire, Inc.
ROCKVILLE, Md. and SUZHOU, China, May 12, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, integrated biopharmaceutical company engaged in the discovery, development and commercialization of...
Agios Submits sNDA to FDA for U.S. Accelerated Approval of Mitapivat in Sickle Cell Disease
GlobeNewswire, Inc.
sNDA submission follows agreement with FDA on confirmatory trial, a requirement of the accelerated approval pathway Confirmatory trial designed to demonstrate clinical benefit of mitapivat on reducing transfusion burden in sickle cell disease...
Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2026 Congress
GlobeNewswire, Inc.
Oral presentation of data from RALLY-MF phase 2 trial of DISC-0974 in patients with myelofibrosis and anemia Additional abstracts highlighting updates on HELIOS open label extension study of bitopertin in EPP, EPP LIGHT study (patient survey on...
Cellectis to Present Clinical Data on Lasme-cel and Eti-cel at EHA 2026 Annual Congress
GlobeNewswire, Inc.
NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving cell and gene therapies, today...
Beam Therapeutics to Present Updated Biomarker Data from Phase 1/2 BEACON Trial Further Underscoring Risto-cel’s Ability to Restore Red Blood Cell Health and Function in Sickle Cell Disease at EHA2026
GlobeNewswire, Inc.
CAMBRIDGE, Mass., May 12, 2026 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the company will present updated biomarker data...
ORYZON to Present Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemia at EHA 2026
GlobeNewswire, Inc.
In first line, iadademstat with azacitidine and venetoclax continues to show favorable safety and 100% ORR, with a composite complete remission rate (CRc) of 93% (with 79% CR), and an estimated 12-month OS of 74% In FLT3‑mutated...
Ajax Therapeutics Announces Oral Presentation of Clinical Results from AJX-101, a Phase I study of AJ1-11095, a First-in-Class Type II JAK2 Inhibitor, at the European Hematology Society (EHA) 2026 Congress
GlobeNewswire, Inc.
– Company unveils first proof-of concept clinical data of AJ1-11095 in patients with myelofibrosis who have been previously treated with a type I JAK2 Inhibitor – NEW YORK and CAMBRIDGE, Mass., May 12, 2026 (GLOBE NEWSWIRE) -- Ajax Therapeutics,...
Pioneering screening test offers potential to find more aggressive prostate cancers
GlobeNewswire, Inc.
STOCKHOLM, June 22, 2026 (GLOBE NEWSWIRE) -- A3P Biomedical, a diagnostics company specializing in prostate cancer screening, today announced the publication of a population-based screening study (N=12,670) in Annals of Internal Medicine.
AG Brown sues Providence Health & Services over illegal treatment of pregnant and nursing employees
Washington State Office of Attorney General
Washington Attorney General Nick Brown today sued Providence Health & Services in King County Superior Court, alleging that Providence repeatedly failed to provide reasonable accommodations required under state law to pregnant and nursing...
BlossomHill Therapeutics to Present Initial Clinical Dose Escalation Data from the Phase 1/1b Trial of BH-30236 in Patients with R/R AML or HR-MDS at EHA2026
GlobeNewswire, Inc.
Treatment with BH-30236, a novel CLK inhibitor, was generally well tolerated as monotherapy and in combination with venetoclax Preliminary anti-leukemic activity observed, including patients that were previously treated with venetoclax based...
Sepsis Clinical Trial Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
GlobeNewswire, Inc.
New York, USA, May 12, 2026 (GLOBE NEWSWIRE) -- Sepsis Clinical Trial Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight The sepsis clinical trial analysis report delivers important...
Veterinary Healthcare Industry Analysis: Market Competition and Future Outlook
EIN Presswire
The Business Research Company's Veterinary Healthcare Industry Analysis: Market Competition and Future Outlook LONDON, GREATER LONDON, UNITED KINGDOM, May 6, 2026 /EINPresswire.com/ -- "The veterinary healthcare sector has seen remarkable growth...
Allarity Therapeutics CEO to Present at Precision Medicine Forum Europe 2026 in Stockholm
GlobeNewswire, Inc.
TARPON SPRINGS, Fla., May 8, 2026 – Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib (2X-121)—a differentiated, dual PARP and WNT pathway...
Repligen Corporation to Present at Bank of America Securities 2026 Global Healthcare Conference
GlobeNewswire, Inc.
WALTHAM, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will participate in the Bank of America Securities 2026 Global...
Equine Healthcare Market Expected to Expand at a 6.4% CAGR Until 2030: Industry Report
EIN Presswire
The Business Research Company's Equine Healthcare Market Expected to Expand at a 6.4% CAGR Until 2030: Industry Report LONDON, GREATER LONDON, UNITED KINGDOM, May 5, 2026 /EINPresswire.com/ -- "The equine healthcare sector has witnessed...
Sign up for:
Swedish Health Press
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.